Matinas BioPharma
effect of oral in a murine acute colitis model day | Matinas BioPharma
Company
Deck Type
Sector
Industry
Deck date
February 2024
Slide
25 of 29
Similar slides by Matinas BioPharma
See diffirences between slides (animation)
Investor Presentation
March 2024
effect of oral in a murine acute colitis model oss i | Matinas BioPharma
Investor Presentation
January 2024
effect of oral in a murine acute colitis model i day | Matinas BioPharma
Related slides by other companies
Equillium
Investor Presentation
February 2024
reverses immune mediated hair loss in a mouse model | Equillium
Arbutus Biopharma
Investor Presentation
January 2024
small molecule oral inhibitor for | Arbutus Biopharma
Larimar Therapeutics
Investor Presentation
November 2023
extends survival in deficient mice | Larimar Therapeutics
Kymera
Investor Day
December 2021
full and durable regressions across multiple in preclinical tumor models | Kymera
Other recent decks by Matinas BioPharma
See all presentations (7 decks)
Investor Presentation
March 2024
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io